Literature DB >> 33754063

Trio cooperates with Myh9 to regulate neural crest-derived craniofacial development.

Shuyu Guo1, Li Meng1, Haojie Liu1, Lichan Yuan1, Na Zhao1, Jieli Ni1, Yang Zhang1, Jingjing Ben2, Yi-Ping Li3, Junqing Ma1.   

Abstract

Trio is a unique member of the Rho-GEF family that has three catalytic domains and is vital for various cellular processes in both physiological and developmental settings. TRIO mutations in humans are involved in craniofacial abnormalities, in which patients present with mandibular retrusion. However, little is known about the molecular mechanisms of Trio in neural crest cell (NCC)-derived craniofacial development, and there is still a lack of direct evidence to assign a functional role to Trio in NCC-induced craniofacial abnormalities.
Methods: In vivo, we used zebrafish and NCC-specific knockout mouse models to investigate the phenotype and dynamics of NCC development in Trio morphants. In vitro, iTRAQ, GST pull-down assays, and proximity ligation assay (PLA) were used to explore the role of Trio and its potential downstream mediators in NCC migration and differentiation.
Results: In zebrafish and mouse models, disruption of Trio elicited a migration deficit and impaired the differentiation of NCC derivatives, leading to craniofacial growth deficiency and mandibular retrusion. Moreover, Trio positively regulated Myh9 expression and directly interacted with Myh9 to coregulate downstream cellular signaling in NCCs. We further demonstrated that disruption of Trio or Myh9 inhibited Rac1 and Cdc42 activity, specifically affecting the nuclear export of β-catenin and NCC polarization. Remarkably, craniofacial abnormalities caused by trio deficiency in zebrafish could be partially rescued by the injection of mRNA encoding myh9, ca-Rac1, or ca-Cdc42. Conclusions: Here, we identified that Trio, interacting mostly with Myh9, acts as a key regulator of NCC migration and differentiation during craniofacial development. Our results indicate that trio morphant zebrafish and Wnt1-cre;Triofl/fl mice offer potential model systems to facilitate the study of the pathogenic mechanisms of Trio mutations causing craniofacial abnormalities. © The author(s).

Entities:  

Keywords:  Myh9; Neural crest cells; Trio; cell migration.; craniofacial deformity

Mesh:

Substances:

Year:  2021        PMID: 33754063      PMCID: PMC7977452          DOI: 10.7150/thno.51745

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


  74 in total

Review 1.  Cranial neural crest cells on the move: their roles in craniofacial development.

Authors:  Dwight R Cordero; Samantha Brugmann; Yvonne Chu; Ruchi Bajpai; Maryam Jame; Jill A Helms
Journal:  Am J Med Genet A       Date:  2010-12-10       Impact factor: 2.802

Review 2.  Rho GTPases: biochemistry and biology.

Authors:  Aron B Jaffe; Alan Hall
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

3.  Cranial neural crest cells regulate head muscle patterning and differentiation during vertebrate embryogenesis.

Authors:  Ariel Rinon; Shlomi Lazar; Heather Marshall; Stine Büchmann-Møller; Adi Neufeld; Hadas Elhanany-Tamir; Makoto M Taketo; Lukas Sommer; Robb Krumlauf; Eldad Tzahor
Journal:  Development       Date:  2007-07-25       Impact factor: 6.868

4.  Distinct functions of Trio GEF domains in axon outgrowth of cerebellar granule neurons.

Authors:  Tao Tao; Jie Sun; Yajing Peng; Pei Wang; Xin Chen; Wei Zhao; Yeqiong Li; Lisha Wei; Wei Wang; Yanyan Zheng; Ye Wang; Xuena Zhang; Min-Sheng Zhu
Journal:  J Genet Genomics       Date:  2019-02-23       Impact factor: 4.275

5.  Germline Mutations in FAF1 Are Associated With Hereditary Colorectal Cancer.

Authors:  Laia Bonjoch; Sebastià Franch-Expósito; Pilar Garre; Sami Belhadj; Jenifer Muñoz; Coral Arnau-Collell; Marcos Díaz-Gay; Anna Gratacós-Mulleras; Giulia Raimondi; Clara Esteban-Jurado; Yasmin Soares de Lima; Cristina Herrera-Pariente; Miriam Cuatrecasas; Teresa Ocaña; Antoni Castells; Cristina Fillat; Gabriel Capellá; Francesc Balaguer; Trinidad Caldés; Laura Valle; Sergi Castellví-Bel
Journal:  Gastroenterology       Date:  2020-03-14       Impact factor: 22.682

6.  Par3 controls neural crest migration by promoting microtubule catastrophe during contact inhibition of locomotion.

Authors:  Rachel Moore; Eric Theveneau; Sara Pozzi; Paula Alexandre; Joanna Richardson; Anne Merks; Maddy Parsons; Jubin Kashef; Claudia Linker; Roberto Mayor
Journal:  Development       Date:  2013-10-30       Impact factor: 6.868

7.  The Rho guanine nucleotide exchange factor Trio is required for neural crest cell migration and interacts with Dishevelled.

Authors:  Marie-Claire Kratzer; Sarah F S Becker; Anita Grund; Anne Merks; Jakub Harnoš; Vítězslav Bryja; Klaudia Giehl; Jubin Kashef; Annette Borchers
Journal:  Development       Date:  2020-05-22       Impact factor: 6.862

8.  mTOR acts as a pivotal signaling hub for neural crest cells during craniofacial development.

Authors:  Xuguang Nie; Jinxuan Zheng; Christopher L Ricupero; Ling He; Kai Jiao; Jeremy J Mao
Journal:  PLoS Genet       Date:  2018-07-05       Impact factor: 5.917

9.  From Pioneer to Repressor: Bimodal foxd3 Activity Dynamically Remodels Neural Crest Regulatory Landscape In Vivo.

Authors:  Martyna Lukoseviciute; Daria Gavriouchkina; Ruth M Williams; Tatiana Hochgreb-Hagele; Upeka Senanayake; Vanessa Chong-Morrison; Supat Thongjuea; Emmanouela Repapi; Adam Mead; Tatjana Sauka-Spengler
Journal:  Dev Cell       Date:  2018-12-03       Impact factor: 12.270

10.  A Novel Human Pluripotent Stem Cell-Derived Neural Crest Model of Treacher Collins Syndrome Shows Defects in Cell Death and Migration.

Authors:  Felipe Serrano; William George Bernard; Alessandra Granata; Dharini Iyer; Ben Steventon; Matthew Kim; Ludovic Vallier; Laure Gambardella; Sanjay Sinha
Journal:  Stem Cells Dev       Date:  2018-12-18       Impact factor: 3.272

View more
  3 in total

1.  ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.

Authors:  Wenjing Yang; Beili Wang; Qian Yu; Te Liu; Tong Li; Tongtong Tian; Anli Jin; Lin Ding; Wei Chen; Hao Wang; Jingrong Xian; Baishen Pan; Jian Zhou; Jia Fan; Xinrong Yang; Wei Guo
Journal:  Theranostics       Date:  2022-08-21       Impact factor: 11.600

2.  Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis.

Authors:  Zekun Wang; Yaming Li; Jingwen Yang; Yiran Liang; Xiaolong Wang; Ning Zhang; Xiaoli Kong; Bing Chen; Lijuan Wang; Wenjing Zhao; Qifeng Yang
Journal:  Cell Death Dis       Date:  2022-09-08       Impact factor: 9.685

3.  MCM8 is regulated by EGFR signaling and promotes the growth of glioma stem cells through its interaction with DNA-replication-initiating factors.

Authors:  Xiaoliang Wang; Li Zhang; Yifu Song; Yang Jiang; Di Zhang; Run Wang; Tianhao Hu; Sheng Han
Journal:  Oncogene       Date:  2021-06-15       Impact factor: 9.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.